Impact BioMedical Inc.
IBO
$0.8501
-$0.0799-8.59%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -100.00% |
| SG&A Expenses | 28.86% | 22.42% | 47.90% | 49.04% | 19.84% |
| Depreciation & Amortization | 0.18% | 0.18% | 0.45% | 0.63% | 0.45% |
| Other Operating Expenses | 276.47% | 127.27% | 142.86% | -- | -- |
| Total Operating Expenses | -6.58% | -3.16% | 13.39% | 17.43% | 12.93% |
| Operating Income | 6.58% | 3.16% | -15.03% | -19.17% | -14.58% |
| Income Before Tax | 113.08% | 47.27% | 42.10% | 43.25% | -130.87% |
| Income Tax Expenses | -- | -- | -- | -- | -2,164.84% |
| Earnings from Continuing Operations | 116.86% | 42.95% | 37.14% | 38.32% | -74.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -72.61% | -74.47% | -70.91% | 17.21% | -51.48% |
| Net Income | 118.48% | 41.73% | 35.53% | 40.05% | -93.20% |
| EBIT | 6.58% | 3.16% | -15.03% | -19.17% | -14.58% |
| EBITDA | -0.49% | -13.76% | -51.23% | -77.32% | -57.54% |
| EPS Basic | 259.60% | -135.49% | -73.32% | 15.35% | -92.86% |
| Normalized Basic EPS | 360.06% | -366.25% | -264.11% | -71.77% | -37.01% |
| EPS Diluted | -81.58% | -137.24% | -89.48% | 1.02% | -111.47% |
| Normalized Diluted EPS | -197.41% | -366.25% | -264.11% | -71.77% | -37.01% |
| Average Basic Shares Outstanding | -78.37% | -57.45% | -35.99% | -14.54% | 0.00% |
| Average Diluted Shares Outstanding | -56.91% | -57.45% | -35.99% | -14.54% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
